Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 01 Oct 2026. Factsheet Jun 2026. About · Disclosures
Nippon India Pharma Fund Direct Plan Bonus Plan Bonus
Nippon India Mutual Fund₹628.4076
As on 01 Oct 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +12.36% | — | — |
| 3 year | +17.78% | — | — |
| 5 year | +13.09% | — | — |
- Sharpe
- 0.87
- Std dev
- 14.77%
- Beta
- 0.88
Returns
From NAVs through 01 Oct 2026
Calendar years
Rolling 1-year · 51 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
37 holdings · portfolio as on 30 May 2026
- 13.35%Sun Pharmaceuticals Industries LtdHealthcare
- 7.31%Lupin LtdHealthcare
- 6.72%Dr Reddy's Laboratories LtdHealthcare
- 6.16%Cipla LtdHealthcare
- 5.8%Divi's Laboratories LtdHealthcare
- 5.2%Apollo Hospitals Enterprise LtdHealthcare
- 3.94%Mankind Pharma LtdHealthcare
- 3.68%Medplus Health Services LtdHealthcare
- 3.43%Sai Life Sciences LtdHealthcare
- 3.21%Ajanta Pharma LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is Nippon India Pharma Fund Direct Plan Bonus Plan Bonus NAV today?
- The latest NAV of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus is ₹628.4076 as on 01 Oct 2026.
How has Nippon India Pharma Fund Direct Plan Bonus Plan Bonus performed vs its category?
- 1-year return +12.36%. Past performance does not guarantee future returns.
What are the returns of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- Trailing returns from published NAVs: 1 year +12.36%, 3 year +17.78% a year, 5 year +13.09% a year, since our first NAV +13.45% a year. Past performance does not guarantee future returns.
How would a SIP in Nippon India Pharma Fund Direct Plan Bonus Plan Bonus have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +17.78%. It is not a forecast.
What is the expense ratio and fund size of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- For Nippon India Pharma Fund Direct Plan Bonus Plan Bonus, the expense ratio is 0.79% and fund size (AUM) is ₹8635.75 Cr.
What is the ISIN of Nippon India Pharma Fund Direct Plan Bonus Plan Bonus?
- The ISIN for Nippon India Pharma Fund Direct Plan Bonus Plan Bonus is INF204K01I27.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.